These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5312991)

  • 1. Furazolidone in paediatric cholera.
    Karchmer AW; Curlin GT; Huq MI; Hirschhorn N
    Bull World Health Organ; 1970; 43(3):373-8. PubMed ID: 5312991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-resistant strains of E1 Tor vibrio in the Philippines and the use of furalazine for chemotherapy.
    Kobari K; Takakura I; Nakatomi M; Sogame S; Uylangco C
    Bull World Health Organ; 1970; 43(3):365-71. PubMed ID: 5312990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of tetracycline and furazolidone in cholera.
    Pierce NF; Banwell JG; Mitra RC; Caranasos GJ; Keimowitz RI; Thomas J; Mondal A
    Br Med J; 1968 Aug; 3(5613):277-80. PubMed ID: 4873660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on cholera treated orally and intravenously with antibiotics. With particular reference to the number of vibrios excreted in the stool.
    Kobari K; Uylangco C; Vasco J; Takahira Y; Shimizu N
    Bull World Health Organ; 1967; 37(5):751-62. PubMed ID: 5300878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.
    Rabbani GH; Islam MR; Butler T; Shahrier M; Alam K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1447-50. PubMed ID: 2684006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients.
    Francis TI; Lewis EA; Oyediran AB; Okubadejo OA; Montefiore D; Onyewotu II; Mohammed I; Ayoola EA; Vincent R
    J Trop Med Hyg; 1971 Aug; 74(8):172-6. PubMed ID: 4936576
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins.
    Rabbani GH
    Dan Med Bull; 1996 Apr; 43(2):173-85. PubMed ID: 8741209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of furoxone: a perspective.
    Phillips KF; Hailey FJ
    J Int Med Res; 1986; 14(1):19-29. PubMed ID: 3514312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of the use of bacteriophage in the treatment of cholera.
    Marcuk LM; Nikiforov VN; Scerbak JF; Levitov TA; Kotljarova RI; Naumsina MS; Davydov SU; Monsur KA; Rahman MA; Latif MA; Northrup RS; Cash RA; Hug I; Dey CR; Phillips RA
    Bull World Health Organ; 1971; 45(1):77-83. PubMed ID: 4946956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of tetracycline and norfloxacin in the treatment of acute severe watery diarrhea.
    Moolasart P; Eampokalap B; Supaswadikul S
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):108-11. PubMed ID: 9740281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera: synopsis of clinical aspects and principles of treatment.
    Frost WH
    Can Med Assoc J; 1976 Sep; 115(5):401-3. PubMed ID: 953914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Kar SK; Patnaik B
    Int J Infect Dis; 2010 May; 14(5):e384-9. PubMed ID: 19781971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy of cholera in children.
    Lindenbaum J; Greenough WB; Islam MR
    Bull World Health Organ; 1967; 37(4):529-38. PubMed ID: 5301733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endemic cholera in Delhi, 1995: analysis of data from a sentinel centre.
    Singh J; Sachdeva V; Bhatia R; Bora D; Jain DC; Sokhey J
    J Diarrhoeal Dis Res; 1998 Jun; 16(2):66-73. PubMed ID: 9805411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Broad Street pump revisited: response of volunteers to ingested cholera vibrios.
    Hornick RB; Music SI; Wenzel R; Cash R; Libonati JP; Snyder MJ; Woodward TE
    Bull N Y Acad Med; 1971 Oct; 47(10):1181-91. PubMed ID: 5286453
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.
    Mosley WH; Ahmad S; Benenson AS; Ahmed A
    Bull World Health Organ; 1968; 38(5):777-85. PubMed ID: 5303331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriological studies of convalescent carriers of cholera vibrios.
    Pierce NF; Banwell JC; Gorbach SL; Mitra RC; Mondal A; Manji PM
    Indian J Med Res; 1969 Apr; 57(4):706-12. PubMed ID: 5805373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.